Community-level antimicrobial resistance in response to temporal gradients of antibiotic stress
Aapalampi, Inga-Katariina (2023-05-18)
Community-level antimicrobial resistance in response to temporal gradients of antibiotic stress
Aapalampi, Inga-Katariina
(18.05.2023)
Julkaisu on tekijänoikeussäännösten alainen. Teosta voi lukea ja tulostaa henkilökohtaista käyttöä varten. Käyttö kaupallisiin tarkoituksiin on kielletty.
suljettu
Julkaisun pysyvä osoite on:
https://urn.fi/URN:NBN:fi-fe2023061555256
https://urn.fi/URN:NBN:fi-fe2023061555256
Tiivistelmä
The development of antimicrobial resistance poses a global threat to human health. However, antimicrobial resistance has mainly been studied from a clinical perspective in single bacterial isolates. The purpose of this thesis was to investigate 1) how a resistance phenotype developed at the community level in a temporally variable environment and 2) how different evolutionary histories of bacterial community members influenced the community-scale resistance phenotype. Three treatment groups of bacteria with different evolutionary histories (ampicillin-evolved, ancestral, and mixed), were exposed to gradually increasing concentrations of ampicillin reaching a maximum concentration after 30 days, after which the ampicillin stress was removed representing a stress recovery phase. At the end of the ampicillin treatment phase and the recovery phase individual clones were randomly isolated from the samples and phenotyped for their level of ampicillin resistance.
Bacterial communities exposed to higher ampicillin concentrations had greater resistance than those exposed to lower ampicillin concentrations. The resistance of bacteria grown at low ampicillin concentrations increased during the recovery phase, but the resistance of the evolved treatment group grown at the highest ampicillin concentration decreased. Few differences were observed between the ancestral and mixed treatment groups. Overall, the level of resistance was positively correlated with higher ampicillin concentrations. The resistance of the evolved treatment group grown at the highest concentration of ampicillin decreased during the recovery phase, potentially indicating fitness costs of resistance. At low concentrations of ampicillin, resistance increased during the recovery phase, suggesting that resistance did not impose fitness costs. There were almost no differences between the ancestral treatment group and the mixed treatment group, which suggests that the evolved bacteria did not protect sensitive bacteria. Together these findings highlight how community level resistance can vary in response to temporally variable antibiotic concentrations and the role of evolutionary history in this resistance phenotype.
Bacterial communities exposed to higher ampicillin concentrations had greater resistance than those exposed to lower ampicillin concentrations. The resistance of bacteria grown at low ampicillin concentrations increased during the recovery phase, but the resistance of the evolved treatment group grown at the highest ampicillin concentration decreased. Few differences were observed between the ancestral and mixed treatment groups. Overall, the level of resistance was positively correlated with higher ampicillin concentrations. The resistance of the evolved treatment group grown at the highest concentration of ampicillin decreased during the recovery phase, potentially indicating fitness costs of resistance. At low concentrations of ampicillin, resistance increased during the recovery phase, suggesting that resistance did not impose fitness costs. There were almost no differences between the ancestral treatment group and the mixed treatment group, which suggests that the evolved bacteria did not protect sensitive bacteria. Together these findings highlight how community level resistance can vary in response to temporally variable antibiotic concentrations and the role of evolutionary history in this resistance phenotype.
Samankaltainen aineisto
Näytetään aineisto, joilla on samankaltaisia nimekkeitä, tekijöitä tai asiasanoja.
-
Systematic drug screening reveals specific vulnerabilities and co-resistance patterns in endocrine-resistant breast cancer
Kangaspeska S; Bruck O; Aittokallio T; Mpindi JP; Hultsch S; Edgren H; Eldfors S; Jaiswal A; Kallioniemi OBackground: The estrogen receptor (ER) inhibitor tamoxifen reduces breast cancer mortality by 31 % and has served as the standard treatment for ER-positive breast cancers for decades. However, 50 % of advanced ER-positive ... -
spa typing of methicillin resistant Staphylococcus aureus in Southwest Finland in 2007 and 2008: Evaluating a method transition and strain type diversity
Silvola, Jaakko (10.03.2019)Staphylococcus aureus is a major cause of both nosocomial and community acquired infections. Methicillin resistant S. aureus (MRSA) strains complicate the effective antimicrobial treatment of these infections. They are a ...suljettu -
Construction of a deception resistant questionnaire for alleged child sexual abuse victims : enhancing the Finnish Investigative Instrument of Child Sexual Abuse (FICSA)
Haajanen, Juulia (02.05.2019)The prevalence of child sexual abuse (CSA) is seemingly decreasing, but at the same time the number of reported CSA cases is rising, indicating that also unfounded CSA allegations are being processed by the authorities. ...suljettu